Molecular and biological characterization of a new isolate of guinea pig cytomegalovirus

Viruses

Volumn 6, Issue 2, 2014, Pages 448-475

  Schleiss, Mark R ^a   McAllister, Shane ^a   Armién, Anibal G ^b   Hernandez Alvarado, Nelmary ^a   Fernández Alarcón, Claudia ^a   Zabeli, Jason C ^a   Ramaraj, Thiruvarangan ^c   Crow, John A ^c   McVoy, Michael A ^d  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c NATIONAL CENTER FOR GENOME RESOURCES   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CMV immune evasion; Congenital CMV vaccines; Congenital cytomegalovirus infection; Cytomegalovirus strain variation; Guinea pig cytomegalovirus

Indexed keywords

CYTOMEGALOVIRUS VACCINE; RESTRICTION ENDONUCLEASE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; GUINEA PIG MODEL; IMMUNE DEFICIENCY; NONHUMAN; OPEN READING FRAME; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; SALIVARY GLAND; TRANSMISSION ELECTRON MICROSCOPY; VIRUS CHARACTERIZATION; VIRUS GENOME; VIRUS ISOLATION; VIRUS NUCLEOCAPSID; VIRUS STRAIN; WESTERN BLOTTING;

ANIMALS; DNA, VIRAL; FEMALE; GENOME, VIRAL; GUINEA PIGS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MICROSCOPY, ELECTRON, TRANSMISSION; MOLECULAR SEQUENCE DATA; PREGNANCY; ROSEOLOVIRUS; ROSEOLOVIRUS INFECTIONS; SEQUENCE ANALYSIS, DNA; VIRION;

EID: 84893280061     PISSN: 19994915     EISSN: None     Source Type: Journal    
DOI: 10.3390/v6020448     Document Type: Article

References (62)

1. Sung, H.; Schleiss, M.R. Update on the current status of cytomegalovirus vaccines. Expert Rev. Vaccines 2010, 9, 1303-1314.
2. Nigro, G.; Adler, S.P.; La Torre, R.; Best, A.M. Passive immunization during pregnancy for congenital cytomegalovirus infection. N. Engl. J. Med. 2005, 353, 1350-1362.
3. Griffiths, P.; Plotkin, S.; Mocarski, E.; Pass, R.; Schleiss, M.; Krause, P.; Bialek, S. Desirability and feasibility of a vaccine against cytomegalovirus. Vaccine 2013, 31, B197-B203.
4. Krause, P.R.; Bialek, S.R.; Boppana, S.B.; Griffiths, P.D.; Laughlin, C.A.; Ljungman, P.; Mocarski, E.S.; Pass, R.F.; Read, J.S.; Schleiss, M.R.; et al. Priorities for cmv vaccine development. Vaccine 2013, 32, 4-10.
5. Pass, R.F.; Zhang, C.; Evans, A.; Simpson, T.; Andrews, W.; Huang, M.L.; Corey, L.; Hill, J.; Davis, E.; Flanigan, C.; et al. Vaccine prevention of maternal cytomegalovirus infection. N. Engl. J. Med. 2009, 360, 1191-1199.
6. Griffiths, P.D.; Stanton, A.; McCarrell, E.; Smith, C.; Osman, M.; Harber, M.; Davenport, A.; Jones, G.; Wheeler, D.C.; O'Beirne, J.; et al. Cytomegalovirus glycoprotein-b vaccine with mf59 adjuvant in transplant recipients: A phase 2 randomised placebo-controlled trial. Lancet 2011, 377, 1256-1263.
7. Ahlfors, K.; Ivarsson, S.A.; Harris, S. Report on a long-term study of maternal and congenital cytomegalovirus infection in sweden. Review of prospective studies available in the literature. Scand. J. Infect. Dis. 1999, 31, 443-457.
8. Ahlfors, K.; Harris, S.; Ivarsson, S.; Svanberg, L. Secondary maternal cytomegalovirus infection causing symptomatic congenital infection. N. Engl. J. Med. 1981, 305, 284.
9. Boppana, S.B.; Rivera, L.B.; Fowler, K.B.; Mach, M.; Britt, W.J. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N. Engl. J. Med. 2001, 344, 1366-1371.
10. Ross, S.A.; Arora, N.; Novak, Z.; Fowler, K.B.; Britt, W.J.; Boppana, S.B. Cytomegalovirus reinfections in healthy seroimmune women. J. Infect. Dis. 2010, 201, 386-389.
11. Yamamoto, A.Y.; Mussi-Pinhata, M.M.; Boppana, S.B.; Novak, Z.; Wagatsuma, V.M.; Oliveira Pde, F.; Duarte, G.; Britt, W.J. Human cytomegalovirus reinfection is associated with intrauterine transmission in a highly cytomegalovirus-immune maternal population. Am. J. Obstet. Gynecol. 2010, 202, 297 e291-298.
12. Mussi-Pinhata, M.M.; Yamamoto, A.Y.; Moura Brito, R.M.; de Lima Isaac, M.; De Carvalho E, Oliveira, P.F.; Boppana, S.; Britt, W.J. Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population. Clin. Infect. Dis. 2009, 49, 522-528.
13. Ross, S.A.; Fowler, K.B.; Ashrith, G.; Stagno, S.; Britt, W.J.; Pass, R.F.; Boppana, S.B. Hearing loss in children with congenital cytomegalovirus infection born to mothers with preexisting immunity. J. Pediatr. 2006, 148, 332-336.
14. Yamamoto, A.Y.; Mussi-Pinhata, M.M.; Isaac, M.D.; Amaral, F.R.; Carvalheiro, C.G.; Aragon, D.C.; Manfredi, A.K.; Boppana, S.B.; Britt, W.J. Congenital cytomegalovirus infection as a cause of sensorineural hearing loss in a highly immune population. J. Pediatr. Infect. Dis. 2011, 30, 1043-1046.
15. Novak, Z.; Ross, S.A.; Patro, R.K.; Pati, S.K.; Reddy, M.K.; Purser, M.; Britt, W.J.; Boppana, S.B. Enzyme-linked immunosorbent assay method for detection of cytomegalovirus strain-specific antibody responses. Clin. Vaccine Immunol. 2009, 16, 288-290.
16. Yamamoto, A.Y.; Mussi-Pinhata, M.M.; de Deus Wagatsuma, V.M.; Marin, L.J.; Duarte, G.; Figueiredo, L.T. Human cytomegalovirus glycoprotein b genotypes in brazilian mothers and their congenitally infected infants. J. Med. Virol. 2007, 79, 1164-1168.
17. Murthy, S.; Hayward, G.S.; Wheelan, S.; Forman, M.S.; Ahn, J.H.; Pass, R.F.; Arav-Boger, R. Detection of a single identical cytomegalovirus (cmv) strain in recently seroconverted young women. PLoS One 2011, 6, e15949.
18. Kropff, B.; Burkhardt, C.; Schott, J.; Nentwich, J.; Fisch, T.; Britt, W.; Mach, M. Glycoprotein n of human cytomegalovirus protects the virus from neutralizing antibodies. PLoS Pathog. 2012, 8, e1002999.
19. Pati, S.K.; Novak, Z.; Purser, M.; Arora, N.; Mach, M.; Britt, W.J.; Boppana, S.B. Strain-specific neutralizing antibody responses against human cytomegalovirus envelope glycoprotein n. Clin. Vaccine Immunol. 2012, 19, 909-913.
20. Burkhardt, C.; Himmelein, S.; Britt, W.; Winkler, T.; Mach, M. Glycoprotein n subtypes of human cytomegalovirus induce a strain-specific antibody response during natural infection. J. Gen. Virol. 2009, 90, 1951-1961.
21. Sabbaj, S.; Pass, R.F.; Goepfert, P.A.; Pichon, S. Glycoprotein b vaccine is capable of boosting both antibody and cd4 t-cell responses to cytomegalovirus in chronically infected women. J. Infect. Dis. 2011, 203, 1534-1541.
22. Schleiss, M.R. Could therapeutic vaccination of cytomegalovirus-seropositive persons prevent reinfection and congenital virus transmission? J. Infect. Dis. 2011, 203, 1513-1516.
23. Kern, E.R. Pivotal role of animal models in the development of new therapies for cytomegalovirus infections. Antivir. Res. 2006, 71, 164-171.
24. Schleiss, M.R. Nonprimate models of congenital cytomegalovirus (cmv) infection: Gaining insight into pathogenesis and prevention of disease in newborns. ILAR J. 2006, 47, 65-72.
25. Yue, Y.; Wang, Z.; Abel, K.; Li, J.; Strelow, L.; Mandarino, A.; Eberhardt, M.K.; Schmidt, K.A.; Diamond, D.J.; Barry, P.A. Evaluation of recombinant modified vaccinia ankara virus-based rhesus cytomegalovirus vaccines in rhesus macaques. Med. Microbiol. Immunol. 2008, 197, 117-123.
26. Bia, F.J.; Miller, S.A.; Davidson, K.H. The guinea pig cytomegalovirus model of congenital human cytomegalovirus infection. Birth. Defects Orig. Artic. Ser. 1984, 20, 233-241.
27. Hartley, J.W.; Rowe, W.P.; Huebner, R.J. Serial propagation of the guinea pig salivary gland virus in tissue culture. Proc. Soc. Exp. Biol. Med. 1957, 96, 281-285.
28. Johnson, K.P.; Connor, W.S. Guinea pig cytomegalovirus: Transplacental transmission. Brief report. Arch. Virol. 1979, 59, 263-267.
29. Schleiss, M.R.; Bourne, N.; Stroup, G.; Bravo, F.J.; Jensen, N.J.; Bernstein, D.I. Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein b vaccine. J. Infect. Dis. 2004, 189, 1374-1381.
30. Bratcher, D.F.; Bourne, N.; Bravo, F.J.; Schleiss, M.R.; Slaoui, M.; Myers, M.G.; Bernstein, D.I. Effect of passive antibody on congenital cytomegalovirus infection in guinea pigs. J. Infect. Dis. 1995, 172, 944-950.
31. Britt, W.J.; Harrison, C. Identification of an abundant disulfide-linked complex of glycoproteins in the envelope of guinea pig cytomegalovirus. Virology 1994, 201, 294-302.
32. Schleiss, M.R.; Bernstein, D.I.; McVoy, M.A.; Stroup, G.; Bravo, F.; Creasy, B.; McGregor, A.; Henninger, K.; Hallenberger, S. The non-nucleoside antiviral, bay 38-4766, protects against cytomegalovirus (cmv) disease and mortality in immunocompromised guinea pigs. Antivir. Res. 2005, 65, 35-43.
33. Fong, C.K.; Bia, F.; Hsiung, G.D. Ultrastructural development and persistence of guinea pig cytomegalovirus in duet cells of guinea pig submaxillary gland. Arch. Virol. 1980, 64, 97-108.
34. Fong, C.K.; Bia, F.; Hsiung, G.D.; Madore, P.; Chang, P.W. Ultrastructural development of guinea pig cytomegalovirus in cultured guinea pig embryo cells. J. Gen. Virol. 1979, 42, 127-140.
35. Fong, C.K.; Brigati, D. Ultrastructural localization of viral antigen in nuclear inclusions of cytomegalovirus infected guinea pig cells. Arch. Virol. 1982, 74, 125-133.
36. Cui, X.; McGregor, A.; Schleiss, M.R.; McVoy, M.A. The impact of genome length on replication and genome stability of the herpesvirus guinea pig cytomegalovirus. Virology 2009, 386, 132-138.
37. Smith, L.M.; McWhorter, A.R.; Masters, L.L.; Shellam, G.R.; Redwood, A.J. Laboratory strains of murine cytomegalovirus are genetically similar to but phenotypically distinct from wild strains of virus. J. Virol. 2008, 82, 6689-6696.
38. Pignatelli, S.; Dal Monte, P.; Rossini, G.; Chou, S.; Gojobori, T.; Hanada, K.; Guo, J.J.; Rawlinson, W.; Britt, W.; Mach, M. et al. Human cytomegalovirus glycoprotein n (gpul73-gn) genomic variants: Identification of a novel subgroup, geographical distribution and evidence of positive selective pressure. J. Gen. Virol. 2003, 84, 647-655.
39. Pignatelli, S.; Dal Monte, P.; Rossini, G.; Lazzarotto, T.; Gatto, M.R.; Landini, M.P. Intrauterine cytomegalovirus infection and glycoprotein n (gn) genotypes. J. Clin. Virol. 2003, 28, 38-43.
40. CLC Workbench software, version 6.0; CLC: Cambridge, MA, USA. Available online: http://www.clcbio.com/products/clc-main-workbench/ (accessed on 23 January 2014).
41. XPlasMap, version 0.99; Available online: http://www.iayork.com/XPlasMap/ (accessed on 16 January 2014).
42. Yamada, S.; Nozawa, N.; Katano, H.; Fukui, Y.; Tsuda, M.; Tsutsui, Y.; Kurane, I.; Inoue, N. Characterization of the guinea pig cytomegalovirus genome locus that encodes homologs of human cytomegalovirus major immediate-early genes, ul128, and ul130. Virology 2009, 391, 99-106.
43. Nozawa, N.; Yamamoto, Y.; Fukui, Y.; Katano, H.; Tsutsui, Y.; Sato, Y.; Yamada, S.; Inami, Y.; Nakamura, K.; Yokoi, M.; et al. Identification of a 1.6 kb genome locus of guinea pig cytomegalovirus required for efficient viral growth in animals but not in cell culture. Virology 2008, 379, 45-54.
44. Yang, D.; Tamburro, K.; Dittmer, D.; Cui, X.; McVoy, M.A.; Hernandez-Alvarado, N.; Schleiss, M.R. Complete genome sequence of pathogenic guinea pig cytomegalovirus from salivary gland homogenates of infected animals. Genome Announc. 2013, 1, e0005413.
45. Kozak, M. An analysis of 5'-noncoding sequences from 699 vertebrate messenger rnas. Nucleic Acids Res. 1987, 15, 8125-8148.
46. ITEM software, Version 9.0; Olympus SIS: Münster, Germany, 2014.
47. Simpson, J.T.; Wong, K.; Jackman, S.D.; Schein, J.E.; Jones, S.J.; Birol, I. Abyss: A parallel assembler for short read sequence data. Genome Res. 2009, 19, 1117-1123.
48. Kanai, K.; Yamada, S.; Yamamoto, Y.; Fukui, Y.; Kurane, I.; Inoue, N. Re-evaluation of the genome sequence of guinea pig cytomegalovirus. J. Gen. Virol. 2011, 92, 1005-1020.
49. Schleiss, M.R.; McGregor, A.; Choi, K.Y.; Date, S.V.; Cui, X.; McVoy, M.A. Analysis of the nucleotide sequence of the guinea pig cytomegalovirus (gpcmv) genome. Virol. J. 2008, 5, 139.
50. Milne, I.; Bayer, M.; Cardle, L.; Shaw, P.; Stephen, G.; Wright, F.; Marshall, D. Tablet--next generation sequence assembly visualization. Bioinformatics 2010, 26, 401-402.
51. Li, H.; Handsaker, B.; Wysoker, A.; Fennell, T.; Ruan, J.; Homer, N.; Marth, G.; Abecasis, G.; Durbin, R. The sequence alignment/map format and samtools. Bioinformatics 2009, 25, 2078-2079.
52. Waterhouse, A.M.; Procter, J.B.; Martin, D.M.; Clamp, M.; Barton, G.J. Jalview version 2-A multiple sequence alignment editor and analysis workbench. Bioinformatics 2009, 25, 1189-1191.
53. SMRT Analysis software, Version 1.4.0; Pacific Biosciences: Menlo Park, CA, USA, 2014. Available online: http://www.pacificbiosciences.com/products/software/secondary-analysis/ (accessed on 16 January 2014).
54. LightCycler Data Analysis Software, version 1.5; Roche: Indianapolis, IN, USA, 2014.
55. Crumpler, M.M.; Choi, K.Y.; McVoy, M.A.; Schleiss, M.R. A live guinea pig cytomegalovirus vaccine deleted of three putative immune evasion genes is highly attenuated but remains immunogenic in a vaccine/challenge model of congenital cytomegalovirus infection. Vaccine 2009, 27, 4209-4218.
56. Hsiung, G.D.; Bia, F.J.; Fong, C.K. Viruses of guinea pigs: Considerations for biomedical research. Microbiol. Rev. 1980, 44, 468-490.
57. Hummel, M.; Zhang, Z.; Yan, S.; DePlaen, I.; Golia, P.; Varghese, T.; Thomas, G.; Abecassis, M.I. Allogeneic transplantation induces expression of cytomegalovirus immediate-early genes in vivo: A model for reactivation from latency. J. Virol. 2001, 75, 4814-4822.
58. Soderberg-Naucler, C.; Fish, K.N.; Nelson, J.A. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 1997, 91, 119-126.
59. Middelkamp, J.N.; Patrizi, G.; Reed, C.A. Light and electron microscopic studies of the guinea pig cytomegalovirus. J. Ultrastruct. Res. 1967, 18, 85-101.
60. Choi, Y.C.; Hsiung, G.D. Cytomegalovirus infection in guinea pigs. II. Transplacental and horizontal transmission. J. Infect. Dis. 1978, 138, 197-202.
61. ATCC History of GPCMV. Available online: http://www.atcc.org/products/all/VR-682.aspx#history/ (accessed on 23 January 2014).
62. Brondke, H.; Schmitz, B.; Doerfler, W. Nucleotide sequence comparisons between several strains and isolates of human cytomegalovirus reveal alternate start codon usage. Arch. Virol. 2007, 152, 2035-2046.